au.\*:("ENHANCE Study Group")
Results 1 to 1 of 1
Selection :
Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE : Further evidence for survival and safety and implications for early treatmentVINCENT, Jean-Louis; BERNARD, Gordon R; WONG, Kar et al.Critical care medicine. 2005, Vol 33, Num 10, pp 2266-2277, issn 0090-3493, 12 p.Article
